METTL13 and urinary bladder cancer: In summary, these results suggest that the METTL13-dependent inhibition of bladder cancer cell migration and invasion is mediated by the downregulation of adhesion molecules and a reduction in extracellular matrix tissue degradation due to matrix metalloproteinase (MMP).